New pill shows great promise in fighting COVID-19. An experimental pill reduced the risk of hospitalization and death by 89 percent in high-risk people infected with the coronavirus, Pfizer announced Friday. The results were so impressive that the company said it is rushing data to regulators “as soon as possible.”Continue Reading

THURSDAY, Nov. 4, 2021 (HealthDay News) — All U.S. adults younger than 60 should be vaccinated against hepatitis B, the Advisory Committee on Immunization Practices recommended Wednesday. Until now, the shots were recommended only for certain groups of adults, including prisoners, health care workers, international travelers, people with diabetes andContinue Reading

THURSDAY, Nov. 4, 2021 (HealthDay News) — Here’s some comforting news for people who struggle with inflammatory bowel disease and worry that the immune-suppressing drugs they must take might blunt their response to COVID-19 vaccines: New research finds vaccination triggers a strong immune reaction in these patients. “At eight weeks,Continue Reading